The Almeria-based multinational Vellsam Materias Bioactivas, the University of Granada and the company Granada La Palma have signed a collaboration agreement for the creation of a research chair on the health effects of the use of biotechnological products in tomato cultivation.
This is the third chair signed between Vellsam and the UGR, which Granada La Palma has joined on this occasion, after those previously created for research against cancer stem cells, the first, and innovation in nutrition and health, the second.
The agreement was concluded following a recent visit by a delegation from Vellsam Materias Bioactivas, led by its managing directors, María Zamora and Francisco Castillo, as well as its Marketing Director, María Castillo, together with executives from the University of Granada, headed by its Rector, Pilar Aranda, and the President of the co-operative, Pedro Ruiz, to the latter's facilities. The aim of the visit was to lay the foundations for the creation of a joint research chair between the three parties.
The chair will focus on studying the effects on health derived from the use of Vellsam Materias Bioactivas' biotechnological products during tomato production.
"We are convinced that this collaboration will generate significant and beneficial results both for the sector and for society as a whole", said all the parties involved after the signing of this agreement, which will deepen the knowledge on the impact of these products on human health and strengthen the quality and safety of the fruit; undoubtedly, a milestone on the road to excellence and innovation in tomato cultivation.
Vellsam Materias Bioactivas has been working for decades as a pioneer in the research, design and production of biotechnological solutions (biostimulants and plant nutrients) with the aim of improving the way food is grown around the world.